Philip Morris stock falls, FDA panel says evidence doesn't back claim iQOS cuts disease risk

An FDA advisory committee voted against Philip Morris' claim that iQOS cuts the risk of tobacco-related diseases.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>